Catalogue context
The allocated records support several practical ways to organize a search: by named target, by species, and by the product description supplied for that record. Those are catalogue relationships. They should not be converted into claims about disease, diagnosis, prognosis, or clinical application.
Search by the target named in the record, including Osteopontin, NGAL (Lipocalin-2), Cystatin C, Hemopexin, Apolipoprotein H/ApoH, Serum Amyloid A, Haptoglobin, CRP, and SIL2-R.
Evidence status: target names are supplier-provided catalogue metadata. Products sharing a target name are not presumed interchangeable.
The collection includes human, rat, mouse, dog, sheep, bovine, and chicken records. Species is a selection attribute: confirm that the intended sample and study design match the specific product record.
Evidence status: species is stated in the supplied product names. The catalogue record—not a shared target label—defines the product being reviewed.
The Hexanoyl-Lysine (HEL) record is described as a biomarker for early-stage oxidation of n:6 polyunsaturated fatty acid. This statement is reproduced as supplied; it does not establish how the kit performs in a particular matrix or study.
Evidence status: this description is supplied for product 8967446 only and should not be generalized to the other records.
Other allocated records name Alpha 1-Acid Glycoprotein, CRP, and Osteopontin across different species. These links support record review, not interpretation of biological or clinical roles.
Evidence status: names, applications, and species are shown only as supplied in the individual product records.
Interpretation boundary
Selecting a kit is a catalogue decision. Validating an assay is a laboratory responsibility involving the intended sample context, protocol, controls, data handling, and documented acceptance criteria. Keep those steps distinct so that a target name or catalogue description is not mistaken for a conclusion about a specimen or subject.
Confirm the target, species, catalogue number, and the product record you intend to evaluate. Similar target names do not by themselves establish interchangeability.
Read the supplied protocol and documentation carefully. Check the stated sample requirements, preparation steps, measurement range, and any restrictions before planning a run.
Plan appropriate controls and define how results will be reviewed before treating a signal as interpretable. Use the controls and plate-plan guide and the data-quality and reporting guide for related reading.
Establish suitability for the intended laboratory context through your own documented evaluation. Catalogue inclusion alone does not validate an assay for every matrix, study, or decision.
For a structured starting point, read the ELISA assay-selection guide. For interpretation scope, see research biomarkers versus clinical conclusions.